Literature DB >> 21602309

Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory intervention.

Zachary R Healy1, Hua Liu, W David Holtzclaw, Paul Talalay.   

Abstract

BACKGROUND: Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine with keto-enol tautomerase activity, rises rapidly in response to inflammation and is elevated in many chronic diseases. Isothiocyanates, such as sulforaphane from broccoli, are very potent inactivators of MIF tautomerase activity. A simple rapid method for determining this activity in tissues and body fluids may therefore be valuable for assessing severity of inflammation and efficacy of intervention.
METHODS: Existing spectrophotometric assays of MIF, based on conversion of methyl L-dopachrome to methyl 5,6-dihydroxyindole-2-carboxylate and associated loss of absorption at 475 nm, lack sensitivity. Assay sensitivity and efficiency were markedly improved by reducing the nonenzymatic rate, by lowering pH to 6.2, replacing phosphate (which catalyzes the reaction) with Bis-Tris buffer, and converting to a microtiter plate format.
RESULTS: A structure-potency study of MIF tautomerase inactivation by isothiocyanates showed that sulforaphane, benzyl, n-hexyl, and phenethyl isothiocyanates were especially potent. MIF tautomerase could be readily quantified in human urine concentrated by ultrafiltration. This activity comprised: (i) a heat-labile, sulforaphane-inactivated macromolecular fraction (presumably MIF) that was concentrated during ultrafiltration; (ii) a flow-through fraction, with constant activity during filtration, that was heat stable and insensitive to sulforaphane. Administration of the sulforaphane precursor glucoraphanin to human volunteers almost completely abolished urinary tautomerase activity, which recovered over many hours.
CONCLUSION: A simple, rapid, quantitative MIF tautomerase assay has been developed as a potential biomarker for assessing inflammatory severity and effectiveness of intervention. IMPACT: An improved assay for measuring MIF tautomerase activity and its applications are described. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602309      PMCID: PMC3132381          DOI: 10.1158/1055-9965.EPI-11-0279

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  36 in total

1.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.

Authors:  Yousef Al-Abed; Darrin Dabideen; Bayan Aljabari; Aline Valster; Davorka Messmer; Mahendar Ochani; Mahira Tanovic; Kanta Ochani; Michael Bacher; Ferdinando Nicoletti; Christine Metz; Valentin A Pavlov; Edmund J Miller; Kevin J Tracey
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

3.  A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease.

Authors:  Aaron P Kithcart; Gina M Cox; Thais Sielecki; Abigail Short; James Pruitt; Tracey Papenfuss; Todd Shawler; Ingrid Gienapp; Abhay R Satoskar; Caroline C Whitacre
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

4.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

5.  Stimulation of phagocytosis by sulforaphane.

Authors:  Hiroyuki Suganuma; Jed W Fahey; Kelley E Bryan; Zachary R Healy; Paul Talalay
Journal:  Biochem Biophys Res Commun       Date:  2011-01-08       Impact factor: 3.575

6.  Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.

Authors:  K Bendrat; Y Al-Abed; D J Callaway; T Peng; T Calandra; C N Metz; R Bucala
Journal:  Biochemistry       Date:  1997-12-09       Impact factor: 3.162

7.  Macrophage migration inhibitory factor.

Authors:  John A. Baugh; Richard Bucala
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

8.  Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates.

Authors:  Kristin K Brown; Frances H Blaikie; Robin A J Smith; Joel D A Tyndall; Hongqi Lue; Jürgen Bernhagen; Christine C Winterbourn; Mark B Hampton
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

9.  Catalytic role of the amino-terminal proline in 4-oxalocrotonate tautomerase: affinity labeling and heteronuclear NMR studies.

Authors:  J T Stivers; C Abeygunawardana; A S Mildvan; G Hajipour; C P Whitman; L H Chen
Journal:  Biochemistry       Date:  1996-01-23       Impact factor: 3.162

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  18 in total

1.  Macrophage migration inhibitory factor covalently complexed with phenethyl isothiocyanate.

Authors:  Joel D A Tyndall; Hongqi Lue; Malcolm T Rutledge; Jurgen Bernhagen; Mark B Hampton; Sigurd M Wilbanks
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-08-29

2.  Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.

Authors:  Joshua Bloom; Christine Metz; Saisha Nalawade; Julian Casabar; Kai Fan Cheng; Mingzhu He; Barbara Sherry; Thomas Coleman; Thomas Forsthuber; Yousef Al-Abed
Journal:  J Biol Chem       Date:  2016-10-28       Impact factor: 5.157

Review 3.  Isothiocyanates: a class of bioactive metabolites with chemopreventive potential.

Authors:  Gaurav Kumar; Hardeep Singh Tuli; Sonam Mittal; Jitendra Kumar Shandilya; Anil Tiwari; Sardul Singh Sandhu
Journal:  Tumour Biol       Date:  2015-04-03

4.  The indirect antioxidant sulforaphane protects against thiopurine-mediated photooxidative stress.

Authors:  Andrea L Benedict; Elena V Knatko; Albena T Dinkova-Kostova
Journal:  Carcinogenesis       Date:  2012-09-15       Impact factor: 4.944

5.  Neuroprotective effects of sulforaphane after contusive spinal cord injury.

Authors:  Andrea L Benedict; Andrea Mountney; Andres Hurtado; Kelley E Bryan; Ronald L Schnaar; Albena T Dinkova-Kostova; Paul Talalay
Journal:  J Neurotrauma       Date:  2012-09-20       Impact factor: 5.269

6.  Atorvastatin increases lipopolysaccharide-induced expression of tumour necrosis factor-α-induced protein 8-like 2 in RAW264.7 cells.

Authors:  Ming-Wei Liu; Mei-Xian Su; Wei Zhang; Li Wang; Chuan-Yun Qian
Journal:  Exp Ther Med       Date:  2014-05-19       Impact factor: 2.447

7.  Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles.

Authors:  Tatiana Altadill; Irene Campoy; Lucia Lanau; Kirandeep Gill; Marina Rigau; Antonio Gil-Moreno; Jaume Reventos; Stephen Byers; Eva Colas; Amrita K Cheema
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

8.  Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis.

Authors:  Sheela R Damle; Rebecca K Martin; Janet V Cross; Daniel H Conrad
Journal:  Mucosal Immunol       Date:  2016-04-06       Impact factor: 7.313

Review 9.  Brassica-Derived Plant Bioactives as Modulators of Chemopreventive and Inflammatory Signaling Pathways.

Authors:  Christine Sturm; Anika E Wagner
Journal:  Int J Mol Sci       Date:  2017-09-01       Impact factor: 5.923

10.  KEAP1 and Done? Targeting the NRF2 Pathway with Sulforaphane.

Authors:  Albena T Dinkova-Kostova; Jed W Fahey; Rumen V Kostov; Thomas W Kensler
Journal:  Trends Food Sci Technol       Date:  2017-02-16       Impact factor: 12.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.